07/24/2025
3:30 PM | Elevation Oncology (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2025
3:35 PM | Elevation Oncology (Issuer)
Mootz Darcy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2025
3:40 PM | Elevation Oncology (Issuer)
Sandler Alan B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2025
3:20 PM | Cherrington Julie M (Reporting)
Elevation Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2025
3:25 PM | CLACKSON TIMOTHY P (Reporting)
Elevation Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2025
12:48 PM | Elevation Oncology (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
07/23/2025
8:06 AM | Elevation Oncology (Subject)
| Form SC 14D9/A | |
07/23/2025
8:22 AM | Concentra Merger Sub VI, Inc. (Filed by)
Elevation Oncology (Subject)
| Form SC TO-T/A | |
07/23/2025
8:27 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
6:54 PM | BlackRock, Inc. (Filed by)
Elevation Oncology (Subject)
| Form SCHEDULE 13G/A | |
06/23/2025
3:13 PM | Elevation Oncology (Subject)
| Form SC 14D9 | |
Get the Latest News and Ratings for ELEV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. |
06/23/2025
9:22 AM | Concentra Merger Sub VI, Inc. (Filed by)
Elevation Oncology (Subject)
| Form SC TO-T | |
06/18/2025
3:15 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Elevation Oncology (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:25 PM | Elevation Oncology (Issuer)
Mootz Darcy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:05 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
7:10 AM | Elevation Oncology (Subject)
| Form SC14D9C | |
05/15/2025
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
6:00 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
3:21 PM | Elevation Oncology (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/05/2025
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2025
3:15 PM | Elevation Oncology (Filer)
| Form DEF 14A | |
04/24/2025
3:20 PM | Elevation Oncology (Filer)
| Form DEFA14A | |
04/16/2025
8:16 AM | BML Investment Partners, L.P. (Filed by)
Elevation Oncology (Subject)
| Form SCHEDULE 13D | |
04/04/2025
4:11 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2025
6:11 PM | BML Investment Partners, L.P. (Filed by)
Elevation Oncology (Subject)
| Form SCHEDULE 13G | |
03/20/2025
7:08 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2025
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
3:52 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
12:34 PM | Elevation Oncology (Subject)
Logos Global Management LP (Filed by)
| Form SCHEDULE 13G/A | |
02/06/2025
1:52 PM | Elevation Oncology (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
8:33 PM | Elevation Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:15 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:50 PM | Elevation Oncology (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
6:05 PM | Elevation Oncology (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G/A | |
11/14/2024
5:45 PM | Elevation Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
3:28 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Elevation Oncology (Subject)
| Form SC 13G/A | |
11/12/2024
1:22 PM | Elevation Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
10:54 AM | Elevation Oncology (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
Altucher: Turn $900 into $108,000 in just 12 months? (Ad) Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve.
James Altucher says this marks the beginning of “Trump’s Great Gain,” a new crypto bull phase driven by emerging federal policies. He believes certain altcoins could turn $900 into $108,000 — and reveals everything in a new presentation. See Altucher’s Great Gain gameplan here |
11/06/2024
1:40 PM | Elevation Oncology (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G | |
11/06/2024
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:00 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
10:49 AM | Elevation Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/09/2024
8:01 AM | Elevation Oncology (Subject)
Empery Asset Management, LP (Filed by)
| Form SC 13G/A | |
09/18/2024
3:15 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:15 PM | Elevation Oncology (Issuer)
Furlong Tammy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:05 PM | Elevation Oncology (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
| Form SC 13D/A | |
08/06/2024
6:30 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:45 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Free ELEV Stock Alerts